Metlife, Inc. (MET) Tops Q1 EPS by 9c
Tweet
Share
E-mailGet Alerts MET Hot Sheet
Price: $95.69 --0%
Revenue Growth %: +15.8%
Financial Fact:
Other net investment gains (losses): 271M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +15.8%
Financial Fact:
Other net investment gains (losses): 271M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Metlife, Inc. (NYSE: MET) reported Q1 EPS of $1.37, $0.09 better than the analyst estimate of $1.28. Revenue for the quarter came in at $16.7 billion versus the consensus estimate of $16.67 billion.
For earnings history and earnings-related data on Metlife, Inc. (MET) click here.
For earnings history and earnings-related data on Metlife, Inc. (MET) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Macy's (M) Tops Q2 EPS by 28c, Beats on Revenue; Offers FY Guidance
- H.C. Wainwright Reiterates Buy Rating on Ascendis Pharma (ASND)
- H.C. Wainwright Reiterates Neutral Rating on BioMarin Pharmaceutical Inc. (BMRN)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
